GB201710059D0 - Anti-allergen antibodies - Google Patents

Anti-allergen antibodies

Info

Publication number
GB201710059D0
GB201710059D0 GBGB1710059.5A GB201710059A GB201710059D0 GB 201710059 D0 GB201710059 D0 GB 201710059D0 GB 201710059 A GB201710059 A GB 201710059A GB 201710059 D0 GB201710059 D0 GB 201710059D0
Authority
GB
United Kingdom
Prior art keywords
allergen antibodies
allergen
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1710059.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mabylon AG
Original Assignee
Mabylon AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mabylon AG filed Critical Mabylon AG
Priority to GBGB1710059.5A priority Critical patent/GB201710059D0/en
Publication of GB201710059D0 publication Critical patent/GB201710059D0/en
Priority to US16/625,085 priority patent/US20200199207A1/en
Priority to CA3067747A priority patent/CA3067747A1/en
Priority to AU2018286932A priority patent/AU2018286932A1/en
Priority to EP18732775.4A priority patent/EP3641892A1/en
Priority to PCT/EP2018/066430 priority patent/WO2018234383A1/en
Priority to ZA2020/00109A priority patent/ZA202000109B/en
Priority to US17/714,507 priority patent/US20220372117A1/en
Ceased legal-status Critical Current

Links

GBGB1710059.5A 2017-06-23 2017-06-23 Anti-allergen antibodies Ceased GB201710059D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1710059.5A GB201710059D0 (en) 2017-06-23 2017-06-23 Anti-allergen antibodies
US16/625,085 US20200199207A1 (en) 2017-06-23 2018-06-20 Anti-allergen antibodies
CA3067747A CA3067747A1 (en) 2017-06-23 2018-06-20 Anti-allergen antibodies
AU2018286932A AU2018286932A1 (en) 2017-06-23 2018-06-20 Anti-allergen antibodies
EP18732775.4A EP3641892A1 (en) 2017-06-23 2018-06-20 Anti-allergen antibodies
PCT/EP2018/066430 WO2018234383A1 (en) 2017-06-23 2018-06-20 Anti-allergen antibodies
ZA2020/00109A ZA202000109B (en) 2017-06-23 2020-01-08 Anti-allergen antibodies
US17/714,507 US20220372117A1 (en) 2017-06-23 2022-04-06 Anti-allergen antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1710059.5A GB201710059D0 (en) 2017-06-23 2017-06-23 Anti-allergen antibodies

Publications (1)

Publication Number Publication Date
GB201710059D0 true GB201710059D0 (en) 2017-08-09

Family

ID=59523469

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1710059.5A Ceased GB201710059D0 (en) 2017-06-23 2017-06-23 Anti-allergen antibodies

Country Status (1)

Country Link
GB (1) GB201710059D0 (en)

Similar Documents

Publication Publication Date Title
IL268517A (en) Anti-tigit antibodies
IL272227A (en) Anti-tigit antibodies
ZA201905966B (en) Anti-lag3 antibodies
HUE067040T2 (en) Anti-sirpalpha antibodies
GB201709808D0 (en) Antibodies
GB201601073D0 (en) Antibodies
SG10201914130VA (en) GARP-TGF-β ANTIBODIES
ZA202002141B (en) Anti-transthyretin antibodies
GB201610044D0 (en) Antibodies
ZA202000109B (en) Anti-allergen antibodies
GB201603291D0 (en) Antibodies
GB201720970D0 (en) Antibodies
GB201616699D0 (en) Antibodies
ZA202103456B (en) Anti-alpha-synuclein antibodies
IL271067A (en) Anti-trkb antibodies
GB201612337D0 (en) Ant-il-22r antibodies
GB201711785D0 (en) Antibodies
GB201710059D0 (en) Anti-allergen antibodies
GB201717006D0 (en) Anti-OPG antibodies
GB201709818D0 (en) Antibodies
GB201703071D0 (en) Antibodies
GB201701416D0 (en) Anti-OPG antibodies
GB201620414D0 (en) Antibodies
GB201615224D0 (en) Antibodies
GB201613158D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)